BridgeMD
New treatment option for Adhesive Capsulitis
Official title Conservative Treatment of Early Adhesive Capsulitis
ClinicalTrials.gov ID: NCT06041282
What this study is testing
- What it's testing
- A prospective, multicentre, randomized controlled study comparing the efficacy of conservative treatment for early adhesive capsulitis
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 80
You may be able to join if
- Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment;
- Unilateral and primary periarthritis of shoulder
- Age ≥40 years old and ≤80 years old, regardless of gender.
- Forward flexion movement is more than 50% limited compared with the contralateral.
- Duration of disease ≤3 months
You likely can't join if
- Patients with a previous history of shoulder joint surgery
- Patients who did not complete the follow-up within the specified time
- Patients with other shoulder diseases.
- Patient with systemic immune disease.
- Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening
- Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival...
See the full eligibility criteria
- Patients in our hospital who need manual release of periarthritis of shoulder or home rehabilitation treatment;
- Unilateral and primary periarthritis of shoulder
- Age ≥40 years old and ≤80 years old, regardless of gender.
- Forward flexion movement is more than 50% limited compared with the contralateral.
- Duration of disease ≤3 months
- Patients with a previous history of shoulder joint surgery
- Patients who did not complete the follow-up within the specified time
- Patients with other shoulder diseases.
- Patient with systemic immune disease.
- Patients who have participated in clinical trials or are conducting other clinical trials within 3 months before screening
- Patients with serious primary cardiovascular diseases, lung diseases, endocrine and metabolic diseases, or serious diseases affecting their survival, such as tumor or AIDS, are considered not suitable for admission.
- Patients with serious liver diseases, kidney diseases, hematological diseases, such as kidney function (BUN, Cr) more than the upper limit of normal, liver function (ALT, AST, TBIL) more than 2 times the upper limit of...
- Patients with viral hepatitis, infectious diseases, abnormal blood coagulation mechanism and other diseases that researchers consider inappropriate for surgery.
- Pregnant or lactating women, or those planning to get pregnant during the test, with positive urine HCG test results before the test; Menstruating women should wait until their period is over before undergoing surgery.
- Patients with severe neurological and mental diseases.
- Suspected or true history of alcohol and drug abuse.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.